MariMed (OTCMKTS:MRMD) Releases Earnings Results

MariMed (OTCMKTS:MRMD) issued its earnings results on Wednesday. The company reported ($0.01) earnings per share (EPS) for the quarter, hitting analysts’ consensus estimates of ($0.01), Zacks reports. MariMed had a negative return on equity of 5.85% and a negative net margin of 8.94%.

MariMed Trading Up 1.2%

Shares of MRMD traded up $0.00 during midday trading on Wednesday, reaching $0.08. The company had a trading volume of 810,925 shares, compared to its average volume of 568,040. MariMed has a 1-year low of $0.06 and a 1-year high of $0.23. The stock has a market cap of $33.51 million, a PE ratio of -2.80 and a beta of 1.33. The firm has a 50 day simple moving average of $0.08 and a 200-day simple moving average of $0.09. The company has a quick ratio of 0.38, a current ratio of 1.00 and a debt-to-equity ratio of 1.44.

About MariMed

MariMed Inc is a multi‐state cannabis company focused on the development, ownership and operation of regulated facilities for the medical and adult‐use cannabis markets. Headquartered in New Bedford, Massachusetts, the company cultivates, processes and dispenses cannabis through an integrated business model that encompasses cultivation, formulation, manufacturing and retail operations. MariMed operates under its own licensed brands and through strategic partnerships to expand its presence across the United States.

The company’s product portfolio includes branded flower, pre‐rolls, vaporizer cartridges, tinctures, edibles and topicals designed to meet a range of consumer and patient needs.